Related Experiment Video
Updated: Jul 25, 2025
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
MicroRNAs as Potential Biomarkers in Gynecological Cancers
Joanna Miśkiewicz1, Aleksandra Mielczarek-Palacz1, Joanna Magdalena Gola2
1Department of Immunology and Serology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland.
Abstract:
MicroRNAs are non-coding transcripts that, thanks to the ability to regulate the mRNA of target genes, can affect the expression of genes encoding tumor suppressors and oncogenes. They can control many important cellular processes, including apoptosis, differentiation, growth, division, and metabolism. Therefore, miRNAs play an important role in the development of many cancers, including gynecological cancers. Ovarian cancer, endometrial cancer, cervical cancer, and vulvar cancer are the most common cancers in women and are a frequent cause of death. The heterogeneity of the pathogenesis of these gynecological diseases makes the diagnostic process a significant obstacle for modern medicine. To date, many studies have been carried out, in which particular attention has been paid to the molecular pathomechanism of these diseases, with particular emphasis on miRNAs. To date, the changed profile of many miRNAs, which influenced the promotion of proliferation, migration, invasion processes and the simultaneous inhibition of programmed cell death, has been proven many times. Detailed understanding of the molecular effects of miRNAs in the above-mentioned gynecological cancers will enable the development of potential predictive and prognostic biomarkers, as well as the optimization of the diagnostic process.
Insights
MicroRNAs (miRNAs) are key regulators in gynecological cancers, influencing cell processes and disease progression. Understanding their molecular role can lead to better diagnostic biomarkers for ovarian, endometrial, and cervical cancers.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are non-coding RNA molecules that regulate gene expression by targeting messenger RNA (mRNA).
- miRNAs play crucial roles in cellular processes such as apoptosis, differentiation, growth, and metabolism.
- Dysregulation of miRNAs is implicated in the development and progression of various cancers, particularly gynecological malignancies.
Purpose of the Study:
- To explore the role of microRNAs in the pathogenesis of common gynecological cancers.
- To investigate how altered miRNA profiles contribute to cancer cell proliferation, migration, invasion, and apoptosis resistance.
- To highlight the potential of miRNAs as predictive and prognostic biomarkers in gynecological oncology.
Main Methods:
- Literature review of studies investigating miRNA expression and function in gynecological cancers.
- Analysis of molecular mechanisms by which miRNAs regulate tumor suppressors and oncogenes.
- Examination of the impact of miRNA dysregulation on key cancer hallmarks.
Main Results:
- Altered miRNA profiles are frequently observed in ovarian, endometrial, and cervical cancers.
- Specific miRNAs have been shown to promote cancer cell proliferation, migration, and invasion.
- Dysregulated miRNAs can inhibit programmed cell death, contributing to tumor development.
- miRNA signatures are associated with the promotion of proliferation, migration, and invasion while inhibiting apoptosis.
Conclusions:
- MicroRNAs are critical players in the molecular pathogenesis of gynecological cancers.
- Understanding miRNA dysregulation offers insights into cancer development and progression.
- miRNAs hold significant promise for the development of novel diagnostic and prognostic biomarkers for improved patient outcomes.
